Pfizer to Acquire InnoPharma, Inc.
- Details
- Category: Pfizer
Pfizer Inc. (NYSE:PFE) and InnoPharma, Inc., a privately held pharmaceutical development company, today announced that they have entered into an agreement under which Pfizer will acquire InnoPharma.
Novartis to license Google "smart lens" technology
- Details
- Category: Novartis
Novartis announced that its eye care division Alcon has entered into an agreement with a division of Google Inc. to in-license its "smart lens" technology for all ocular medical uses. The agreement with Google[x], a team within Google that is devoted to finding new solutions to big global problems,
Abbott to sell its developed markets branded generics pharmaceuticals business to Mylan
- Details
- Category: Abbott
Abbott (NYSE: ABT) announced today that it will sell its developed markets branded generics pharmaceuticals business to Mylan for equity ownership of a newly formed entity that will combine Mylan's existing business and Abbott's developed markets pharmaceuticals business, and will be a publicly traded company.
CliniWorks forms a strategic alliance with Pfizer
- Details
- Category: Pfizer
CliniWorks announced a strategic alliance between its Israeli subsidiary CliniWorks (Israel) Ltd. ("CliniWorks Israel") and Pfizer Inc. ("Pfizer") to jointly advance the parties' respective capabilities in working with healthcare provider organizations to identify and close clinical or quality gaps to improve population health.
Merck Serono announces Global Grants Program to fund scientific innovation
- Details
- Category: Merck Group
Merck Serono, the biopharmaceutical division of Merck, has announced the launch of Merck Global Grants - a program that underscores the company's commitment to funding scientific innovation and independent medical education around the world. The initiative encompasses Merck Serono's complete grants portfolio, including the Grants for Innovation in Research and Grants for Independent Medical Education.
AstraZeneca and Max Planck Institute announce research agreement
- Details
- Category: AstraZeneca
AstraZeneca today announced an agreement with the Max Planck Institute of Molecular Physiology (MPI), Germany, to establish a 'satellite unit' in cardiovascular and metabolic disease (CVMD), linked to AstraZeneca's CVMD Innovative Medicines unit (iMed) in Mölndal, Sweden, to study new modalities chemistry.
Novartis reinforces its leadership in research with new global guidelines for Investigator Initiated Trials (IITs)
- Details
- Category: Novartis
Novartis released today new global guidelines for Investigator Initiated Trials (IITs). Novartis has a strong history of supporting the funding of Investigator Initiated Trials (IITs) governed by internal operating processes and governance measures.
More Pharma News ...
- Roche announces definitive agreement to acquire Seragon Pharmaceuticals
- Amgen receives FDA Breakthrough Therapy Designation for investigational BiTE® antibody blinatumomab in acute lymphoblastic leukemia
- Boehringer Ingelheim Statement on Hepatitis C drug development
- James C. Smith elected to Pfizer's Board of Directors
- Abbott to acquire Veropharm
- Sanofi and Medtronic to form strategic alliance
- Roche Children's Walk 2014